![Jonathan Symonds](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Symonds
Président chez
GSK PLC
Fortune : 2 M $ au 31/05/2026
Profil
Fondateur du centre de fiscalité des entreprises de l'université d'Oxford, Jonathan Richard Symonds est un homme d'affaires britannique qui a été à la tête de 8 entreprises différentes. Il est président non exécutif de GlaxoSmithKline Plc et président de Proteus Digital Health, Inc. M. Symonds est également membre du conseil d'administration de Genomics England Ltd. (ancien président), de Rubius Therapeutics, Inc. et de la Harrow School, et il est directeur des finances et de la stratégie d'entreprise chez Mesoblast Ltd. Auparavant, il a été président du conseil d'administration de The 100 Group, président du conseil de surveillance d'Innocoll Holdings Plc, président d'Innocoll, Inc. et président du conseil de surveillance d'Innocoll AG (toutes deux filiales d'Innocoll Holdings Plc), directeur financier d'AstraZeneca Plc et directeur des finances de Zeneca Group Plc (filiale d'AstraZeneca Plc), directeur financier de Novartis AG, directeur général de The Goldman Sachs Group, Inc, directeur de l'Accounting Standards Board, président de la HSBC Bank Plc et associé de KPMG LLP (Canada). Jonathan Richard Symonds a obtenu un diplôme de premier cycle à l'Université de Hertfordshire.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GSK PLC 0 % | 19/06/2026 | 95 557 ( 0 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Jonathan Symonds
| Sociétés | Poste | Début |
|---|---|---|
| GSK PLC | Président | 01/09/2019 |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Operates genomes project in research and health care for patients with cancer and rare diseases and their families | Directeur/Membre du Conseil | 01/11/2019 |
European Round Table For Industry | Corporate Officer/Principal | - |
Harrow School
 Harrow School Miscellaneous Commercial ServicesCommercial Services Operates as independent boarding school | Directeur/Membre du Conseil | - |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
Anciens postes connus de Jonathan Symonds
| Sociétés | Poste | Fin |
|---|---|---|
| RUBIUS THERAPEUTICS | Directeur/Membre du Conseil | 27/02/2023 |
| HSBC HOLDINGS PLC | Directeur/Membre du Conseil | 18/02/2020 |
HSBC Bank Plc
 HSBC Bank Plc Major BanksFinance Provides commercial and online banking services | Président | 01/08/2018 |
Berg LLC
 Berg LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | 01/07/2017 |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jonathan Symonds
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Diageo Plc
 Diageo Plc Beverages: AlcoholicConsumer Non-Durables Produces, distributes and sells wine, beer and other beverages | Consumer Non-Durables |
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
HSBC Holdings Plc
 HSBC Holdings Plc Major BanksFinance Operates as a bank holding company with interest in providing national banking services | Finance |
HSBC Bank Plc
HSBC Bank Plc Major BanksFinance Provides commercial and online banking services | Finance |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Health Technology |
QinetiQ Group plc
 QinetiQ Group plc Aerospace & DefenseElectronic Technology Provides technology development and consultancy services to the defense, security and related markets | Electronic Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
KPMG LLP (Canada)
 KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Commercial Services |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Accounting Standards Board | |
University of Hertfordshire
 University of Hertfordshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products and medical devices | Health Technology |
Oxford University Centre for Business Taxation | |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Operates genomes project in research and health care for patients with cancer and rare diseases and their families | Commercial Services |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The 100 Group
 The 100 Group Miscellaneous Commercial ServicesCommercial Services Engages in development of business | Commercial Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Harrow School
Harrow School Miscellaneous Commercial ServicesCommercial Services Operates as independent boarding school | Commercial Services |
Felix Pharmaceuticals Pvt Ltd.
 Felix Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic (o-patent) medicines for companion animals | Health Technology |
European Round Table For Industry |
